PBKR03

· Gemma Biotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBKR03, covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease [Phase 1, Phase 2]

See pricing